Manufacturer of Controlled Substances; Application

Pursuant to section 1301.43(a) of title 21 of the Code of Federal Regulations
(CFR), this is notice that on November 9, 1993, Orpharm, Inc., 728 West 19th
Street, Houston, Texas 77008, made application to the Drug Enforcement
Administration (DEA) for registration as a bulk manufacturer of the Schedule
II basic class of controlled substance Methadone (9250).

Any other such applicant and any person who is presently registered with DEA
to manufacture such substances may file comments or objections to the issuance
of the above application and may also file a written request for a hearing
thereon in accordance with 21 CFR 1301.54 and in the form prescribed by 21 CFR
1316.47.

Any such comments, objections, or requests for a hearing may be addressed to
the Director, Office of Diversion Control, Drug Enforcement Administration,
United States Department of Justice, Washington, D.C. 20537, Attention: DEA
Federal Register Representative (CCR), and must be filed no later than January
27, 1994.

Dated: December 21, 1993.

Gene R. Haislip,

Director, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 93Ä31612 Filed 12Ä28Ä93; 8:45 am]

BILLING CODE 4410Ä09ÄM